Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Evaluation of changes in mammographic breast density associated with bazedoxifene, raloxifene, and placebo in postmenopausal women: an ancillary study of protocol 3068A1-301-WW

Trial Profile

Evaluation of changes in mammographic breast density associated with bazedoxifene, raloxifene, and placebo in postmenopausal women: an ancillary study of protocol 3068A1-301-WW

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Aug 2010

At a glance

  • Drugs Bazedoxifene; Raloxifene
  • Indications Menopause
  • Focus Pharmacodynamics
  • Sponsors Pfizer; Wyeth
  • Most Recent Events

    • 17 Aug 2010 Actual end date changed from Sep 2007 to Apr 2010 as reported by ClinicalTrials.gov.
    • 04 Dec 2007 Status change from in progress to completed.
    • 18 Jan 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top